Disease categoriesb | Â | Â | Â | Â | Â | Â | Â |
---|---|---|---|---|---|---|---|
 | CV disorders | Neuromuscular disorder | Encephalopathy | Inflamatory CNS disorders | Epileptic disorders | Other | Total |
Na | 161 | 80 | 181 | 7 | 40 | 61 | 392 |
Demographics | Â | Â | Â | Â | Â | Â | Â |
 Age (mean ± SD) | 67.0 ± 13.4 | 61.6 ± 12.8 | 66.6 ± 12.7 | 61.9 ± 9.3 | 62.5 ± 13.3 | 60.3 ± 9.7 | 65.3 ± 13.1 |
 Sex |  |  |  |  |  |  |  |
  Male | 112 (69.6%) | 59 (73.8%) | 131 (72.4%) | 6 (85.7%) | 27 (67.5%) | 43 (70.5%) | 277 (70.7%) |
  Female | 49 (30.4%) | 21 (26.3%) | 50 (27.6%) | 1 (14.3%) | 13 (32.5%) | 18 (29.5%) | 115 (29.3%) |
 Nicotine consumption (N = 184) | 20 (25.3%) | 12 (28.6%) | 22 (31.0%) | 0 (0.0%) | 8 (36.4%) | 10 (28.6%) | 50 (27.2%) |
 Alcohol consumptionc (N = 260) | 8 (7.3%) | 2 (3.8%) | 10 (8.5%) | 0 (0.0%) | 5 (14.7%) | 1 (2.2%) | 17 (6.5%) |
Past medical history | Â | Â | Â | Â | Â | Â | Â |
 Neurological diseased (N = 386) | 47 (29.7%) | 14 (17.5%) | 43 (24.3%) | 2 (28.6%) | 11 (28.2%) | 11 (18.3%) | 88 (22.8%) |
 Cardiovascular disease (N = 375) | 105 (68.2%) | 48 (61.5%) | 124 (72.5%) | 3 (42.9%) | 25 (65.8%) | 36 (63.2%) | 262 (69.9%) |
 Coronary heart disease (N = 383) | 30 (19.5%) | 6 (7.9%) | 28 (16.5%) | 0 (0.0%) | 2 (5.4%) | 6 (10.5%) | 54 (14.5%) |
 Lung disease (N = 368) | 28 (18.5%) | 8 (10.8%) | 38 (22.5%) | 2 (28.6%) | 7 (18.4%) | 8 (14.0%) | 69 (18.8%) |
 Diabetes (N = 373) | 47 (30.5%) | 20 (26.3%) | 46 (27.1%) | 0 (0.0%) | 12 (32.4%) | 19 (33.3%) | 110 (29.5%) |
 Dyslipidemia (N = 373) | 30 (19.5%) | 11 (14.5%) | 29 (17.1%) | 0 (0.0%) | 7 (18.9%) | 9 (15.8%) | 63 (16.9%) |
 Hypertension (N = 373) | 87 (56.5%) | 38 (50.0%) | 104 (61.2%) | 2 (33.3%) | 20 (54.1%) | 30 (52.6%) | 224 (60.1%) |
Pre-hospital medications | Â | Â | Â | Â | Â | Â | Â |
 Anticoagulant drugs (N = 322) | 50 (36.2%) | 15 (22.7%) | 53 (35.8%) | 1 (14.3%) | 12 (38.7%) | 14 (26.9%) | 107 (33.2%) |
 Immunosuppressants (N = 376) | 18 (11.8%) | 8 (10.1%) | 21 (12.2%) | 1 (14.3%) | 9 (23.1%) | 9 (15.3%) | 45 (12.0%) |
pmRS (N = 322) |  |  |  |  |  |  |  |
 0 | 90 (65.2%) | 38 (57.6%) | 79 (52.3%) | 3 (42.9%) | 17 (50.0%) | 42 (84.0%) | 197 (61.2%) |
 1 | 16 (11.6%) | 13 (19.7%) | 32 (21.2%) | 2 (28.6%) | 8 (23.5%) | 5 (10.0%) | 49 (15.2%) |
 2 | 8 (5.8%) | 6 (9.1%) | 15 (9.9%) | 1 (14.3%) | 3 (8.8%) | 1 (2.0%) | 25 (7.8%) |
 3 | 6 (4.3%) | 2 (3.0%) | 11 (7.3%) | 0 (0.0%) | 3 (8.8%) | 1 (2.0%) | 20 (6.2%) |
 4 | 8 (5.8%) | 4 (6.1%) | 11 (7.3%) | 0 (0.0%) | 1 (2.9%) | 0 (0.0%) | 18 (5.6%) |
 5 | 10 (7.2%) | 3 (4.5%) | 3 (2.0%) | 1 (14.3%) | 2 (5.9%) | 1 (2.0%) | 13 (4.0%) |